RxDoctor Payments Data

Gregory Abbas, MD

Otolaryngology · Louisville, KYNPI 1710983267

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.4% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.

$5,633in general payments, 2019–2025

Across 166 payments — averaging $33.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$881
  • Sanofi$701
  • Optinose US, Inc.$658
  • Stryker$637
  • GSK$479
  • Aerin Medical Inc.$359
  • plus $2K from 24 others
$69,076in research payments, 2019–2025

Across 14 payments — averaging $4934.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$69K

What the payments were for

  • Food & beverage$5,42996%
  • Education$2044%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,633 in reported general payments places this provider in the 85th percentile of 137 otolaryngology providers in Kentucky.

See all otolaryngology providers in Kentucky

Medicare billing

Part B allowed, 2024
$232,459
Medicare patients
709
Services billed
6,595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide344$17,010
Azelastine Hcl63$1,894
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort20$1,177
Fluticasone Propionate55$726
Pilocarpine Hcl15$474
Omeprazole27$281
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$240
Mupirocin35$181
Fluocinolone Acetonide Oil12$177
Doxycycline Hyclate20$132
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid15$108
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$92
Meclizine Hcl11$82
Famotidine18$64
Prednisone37$59

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →